BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38441149)

  • 1. Explore & actuate: the future of personalized medicine in oncology through emerging technologies.
    Babu E; Sen S
    Curr Opin Oncol; 2024 Mar; 36(2):93-101. PubMed ID: 38441149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision Oncology Beyond Genomics: The Future Is Here-It Is Just Not Evenly Distributed.
    Pfohl U; Pflaume A; Regenbrecht M; Finkler S; Graf Adelmann Q; Reinhard C; Regenbrecht CRA; Wedeken L
    Cells; 2021 Apr; 10(4):. PubMed ID: 33920536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Cell Sequencing Technologies in Precision Oncology.
    Melnekoff DT; LaganĂ  A
    Adv Exp Med Biol; 2022; 1361():269-282. PubMed ID: 35230694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One mouse, one patient paradigm: New avatars of personalized cancer therapy.
    Malaney P; Nicosia SV; Davé V
    Cancer Lett; 2014 Mar; 344(1):1-12. PubMed ID: 24157811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges and opportunities in building a health economic framework for personalized medicine in oncology.
    Aguiar PN; Matsas S; Dienstmann R; Ferreira CG
    Per Med; 2023 Sep; 20(5):453-460. PubMed ID: 37602420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network science in clinical trials: A patient-centered approach.
    Manem VSK; Salgado R; Aftimos P; Sotiriou C; Haibe-Kains B
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):135-150. PubMed ID: 29278737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting gene mutation status via artificial intelligence technologies based on multimodal integration (MMI) to advance precision oncology.
    Shao J; Ma J; Zhang Q; Li W; Wang C
    Semin Cancer Biol; 2023 Jun; 91():1-15. PubMed ID: 36801447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future.
    Akhoundova D; Rubin MA
    Cancer Cell; 2022 Sep; 40(9):920-938. PubMed ID: 36055231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing Landscape of Clinical-Genomic Oncology Practice.
    Trivedi H; Kling HM; Treece T; Audeh W; Srkalovic G
    Acta Med Acad; 2019 Apr; 48(1):6-17. PubMed ID: 31264429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
    Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
    Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel omics technology driving translational research in precision oncology.
    Basu A; Budhraja A; Juwayria ; Abhilash D; Gupta I
    Adv Genet; 2021; 108():81-145. PubMed ID: 34844717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.
    McGowan ML; Settersten RA; Juengst ET; Fishman JR
    Urol Oncol; 2014 Feb; 32(2):187-92. PubMed ID: 24445286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).
    Golan T; Milella M; Ackerstein A; Berger R
    J Exp Clin Cancer Res; 2017 Dec; 36(1):192. PubMed ID: 29282151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision oncology: a clinical and patient perspective.
    Lassen UN; Makaroff LE; Stenzinger A; Italiano A; Vassal G; Garcia-Foncillas J; Avouac B
    Future Oncol; 2021 Oct; 17(30):3995-4009. PubMed ID: 34278817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomics and bioinformatics as pillars of precision medicine in oncology.
    Canzoneri R; Lacunza E; Abba MC
    Medicina (B Aires); 2019; 79(Spec 6/1):587-592. PubMed ID: 31864231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systems approach to clinical oncology uses deep phenotyping to deliver personalized care.
    Yurkovich JT; Tian Q; Price ND; Hood L
    Nat Rev Clin Oncol; 2020 Mar; 17(3):183-194. PubMed ID: 31619755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Precision medicine in oncology].
    Mack E
    Inn Med (Heidelb); 2024 Mar; 65(3):194-201. PubMed ID: 37921995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of precision medicine in modern molecular oncology.
    Wang Y; Zheng D
    Clin Genet; 2021 Sep; 100(3):248-257. PubMed ID: 33997970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.